US4880635B1
(en)
*
|
1984-08-08 |
1996-07-02 |
Liposome Company |
Dehydrated liposomes
|
SE8501693D0
(sv)
*
|
1985-04-04 |
1985-04-04 |
Draco Ab |
Novel 16,17-acetalsubstituted androstane-17beta-carboxylic acid esters
|
SE8506015D0
(sv)
*
|
1985-12-19 |
1985-12-19 |
Draco Ab |
Novel 16,17-acetalsubstituted pregnane 21-oic acid derivatives
|
SE8601457D0
(sv)
*
|
1986-04-01 |
1986-04-01 |
Draco Ab |
Compositions of liposomes and b?712-receptor active substances for inhalation
|
US5811119A
(en)
*
|
1987-05-19 |
1998-09-22 |
Board Of Regents, The University Of Texas |
Formulation and use of carotenoids in treatment of cancer
|
US5690954A
(en)
*
|
1987-05-22 |
1997-11-25 |
Danbiosyst Uk Limited |
Enhanced uptake drug delivery system having microspheres containing an active drug and a bioavailability improving material
|
FR2619505B1
(fr)
*
|
1987-08-20 |
1990-08-31 |
Dior Christian Parfums |
Composition a base de phases lamellaires lipidiques hydratees ou de liposomes contenant de la pregnenolone ou un ester de pregnenolone, et composition cosmetique ou pharmaceutique, notamment dermatologique, a activite regeneratrice ou revitalisante, l'incorporant
|
GB8723846D0
(en)
*
|
1987-10-10 |
1987-11-11 |
Danbiosyst Ltd |
Bioadhesive microsphere drug delivery system
|
EP0397774A1
(en)
*
|
1988-02-04 |
1990-11-22 |
Board Of Regents, The University Of Texas System |
Formulation and use of retinoids in treatment of cancer and other diseases
|
US5043165A
(en)
*
|
1988-12-14 |
1991-08-27 |
Liposome Technology, Inc. |
Novel liposome composition for sustained release of steroidal drugs
|
WO1990006775A1
(en)
*
|
1988-12-14 |
1990-06-28 |
Liposome Technology, Inc. |
A novel nonphospholipid liposome composition for sustained release of drugs
|
US4906476A
(en)
*
|
1988-12-14 |
1990-03-06 |
Liposome Technology, Inc. |
Novel liposome composition for sustained release of steroidal drugs in lungs
|
US5100662A
(en)
*
|
1989-08-23 |
1992-03-31 |
The Liposome Company, Inc. |
Steroidal liposomes exhibiting enhanced stability
|
US5922304A
(en)
|
1989-12-22 |
1999-07-13 |
Imarx Pharmaceutical Corp. |
Gaseous precursor filled microspheres as magnetic resonance imaging contrast agents
|
US20020150539A1
(en)
|
1989-12-22 |
2002-10-17 |
Unger Evan C. |
Ultrasound imaging and treatment
|
US5542935A
(en)
|
1989-12-22 |
1996-08-06 |
Imarx Pharmaceutical Corp. |
Therapeutic delivery systems related applications
|
US5469854A
(en)
*
|
1989-12-22 |
1995-11-28 |
Imarx Pharmaceutical Corp. |
Methods of preparing gas-filled liposomes
|
US6088613A
(en)
|
1989-12-22 |
2000-07-11 |
Imarx Pharmaceutical Corp. |
Method of magnetic resonance focused surgical and therapeutic ultrasound
|
US5776429A
(en)
*
|
1989-12-22 |
1998-07-07 |
Imarx Pharmaceutical Corp. |
Method of preparing gas-filled microspheres using a lyophilized lipids
|
US6551576B1
(en)
|
1989-12-22 |
2003-04-22 |
Bristol-Myers Squibb Medical Imaging, Inc. |
Container with multi-phase composition for use in diagnostic and therapeutic applications
|
US6001335A
(en)
*
|
1989-12-22 |
1999-12-14 |
Imarx Pharmaceutical Corp. |
Contrasting agents for ultrasonic imaging and methods for preparing the same
|
US5585112A
(en)
*
|
1989-12-22 |
1996-12-17 |
Imarx Pharmaceutical Corp. |
Method of preparing gas and gaseous precursor-filled microspheres
|
US6146657A
(en)
*
|
1989-12-22 |
2000-11-14 |
Imarx Pharmaceutical Corp. |
Gas-filled lipid spheres for use in diagnostic and therapeutic applications
|
SE9100342D0
(sv)
*
|
1991-02-04 |
1991-02-04 |
Astra Ab |
Novel steroid esters
|
US5888995A
(en)
*
|
1991-02-04 |
1999-03-30 |
Astra Aktiebolag |
Steroid esters
|
SE9100341D0
(sv)
*
|
1991-02-04 |
1991-02-04 |
Astra Ab |
Novel steroids
|
US5874062A
(en)
*
|
1991-04-05 |
1999-02-23 |
Imarx Pharmaceutical Corp. |
Methods of computed tomography using perfluorocarbon gaseous filled microspheres as contrast agents
|
US5205290A
(en)
|
1991-04-05 |
1993-04-27 |
Unger Evan C |
Low density microspheres and their use as contrast agents for computed tomography
|
FR2675146A1
(fr)
*
|
1991-04-10 |
1992-10-16 |
Roussel Uclaf |
Nouveaux derives sterouides de la pregna-1,4-diene-3,20-dione, leur preparation, leur application a la preparation de derives 16,17-methylene dioxy substitues et nouveaux intermediaires.
|
HU221584B
(hu)
*
|
1993-01-08 |
2002-11-28 |
Aktiebolaget Astra |
Új vastagbél- (colon) vagy csípőbél- (ileum) specifikus, cukortartalmú szteroidszármazékok, ezeket tartalmazó gyógyszerkészítmények és előállításuk
|
WO1994028876A1
(en)
*
|
1993-06-07 |
1994-12-22 |
Advanced Therapies, Inc. |
Liposome powders
|
US7083572B2
(en)
|
1993-11-30 |
2006-08-01 |
Bristol-Myers Squibb Medical Imaging, Inc. |
Therapeutic delivery systems
|
US5635206A
(en)
*
|
1994-01-20 |
1997-06-03 |
Hoffmann-La Roche Inc. |
Process for liposomes or proliposomes
|
CH689139A5
(de)
*
|
1995-04-03 |
1998-10-30 |
Cerbios Pharma Sa |
Verfahren zur Herstellung einer liposomalen, in Wasser dispergierbaren, oral zu verabreichenden, festen, trockenen therapeutischen Formulierung.
|
US5997898A
(en)
*
|
1995-06-06 |
1999-12-07 |
Imarx Pharmaceutical Corp. |
Stabilized compositions of fluorinated amphiphiles for methods of therapeutic delivery
|
US6231834B1
(en)
|
1995-06-07 |
2001-05-15 |
Imarx Pharmaceutical Corp. |
Methods for ultrasound imaging involving the use of a contrast agent and multiple images and processing of same
|
US6033645A
(en)
*
|
1996-06-19 |
2000-03-07 |
Unger; Evan C. |
Methods for diagnostic imaging by regulating the administration rate of a contrast agent
|
US6139819A
(en)
*
|
1995-06-07 |
2000-10-31 |
Imarx Pharmaceutical Corp. |
Targeted contrast agents for diagnostic and therapeutic use
|
US6521211B1
(en)
|
1995-06-07 |
2003-02-18 |
Bristol-Myers Squibb Medical Imaging, Inc. |
Methods of imaging and treatment with targeted compositions
|
JP2001507207A
(ja)
|
1996-05-01 |
2001-06-05 |
イマアーレクス・フアーマシユーチカル・コーポレーシヨン |
化合物を細胞に送達する方法
|
TW497974B
(en)
*
|
1996-07-03 |
2002-08-11 |
Res Dev Foundation |
High dose liposomal aerosol formulations
|
US5958378A
(en)
*
|
1996-07-03 |
1999-09-28 |
Research Development Foundation |
High dose liposomal aerosol formulations containing cyclosporin A or budesonide
|
US6414139B1
(en)
|
1996-09-03 |
2002-07-02 |
Imarx Therapeutics, Inc. |
Silicon amphiphilic compounds and the use thereof
|
US5846517A
(en)
|
1996-09-11 |
1998-12-08 |
Imarx Pharmaceutical Corp. |
Methods for diagnostic imaging using a renal contrast agent and a vasodilator
|
WO1998010798A1
(en)
*
|
1996-09-11 |
1998-03-19 |
Imarx Pharmaceutical Corp. |
Improved methods for diagnostic imaging using a contrast agent and a vasodilator
|
GB2321455A
(en)
*
|
1997-01-24 |
1998-07-29 |
Norsk Hydro As |
Lipophilic derivatives of biologically active compounds
|
US6143276A
(en)
*
|
1997-03-21 |
2000-11-07 |
Imarx Pharmaceutical Corp. |
Methods for delivering bioactive agents to regions of elevated temperatures
|
US6537246B1
(en)
|
1997-06-18 |
2003-03-25 |
Imarx Therapeutics, Inc. |
Oxygen delivery agents and uses for the same
|
US6090800A
(en)
*
|
1997-05-06 |
2000-07-18 |
Imarx Pharmaceutical Corp. |
Lipid soluble steroid prodrugs
|
AU6974798A
(en)
*
|
1997-05-06 |
1998-11-27 |
Imarx Pharmaceutical Corp. |
Novel prodrugs comprising fluorinated amphiphiles
|
US7452551B1
(en)
|
2000-10-30 |
2008-11-18 |
Imarx Therapeutics, Inc. |
Targeted compositions for diagnostic and therapeutic use
|
US6416740B1
(en)
|
1997-05-13 |
2002-07-09 |
Bristol-Myers Squibb Medical Imaging, Inc. |
Acoustically active drug delivery systems
|
US6548047B1
(en)
|
1997-09-15 |
2003-04-15 |
Bristol-Myers Squibb Medical Imaging, Inc. |
Thermal preactivation of gaseous precursor filled compositions
|
US6123923A
(en)
*
|
1997-12-18 |
2000-09-26 |
Imarx Pharmaceutical Corp. |
Optoacoustic contrast agents and methods for their use
|
US20010003580A1
(en)
|
1998-01-14 |
2001-06-14 |
Poh K. Hui |
Preparation of a lipid blend and a phospholipid suspension containing the lipid blend
|
US20020061281A1
(en)
*
|
1999-07-06 |
2002-05-23 |
Osbakken Robert S. |
Aerosolized anti-infectives, anti-inflammatories, and decongestants for the treatment of sinusitis
|
US6576224B1
(en)
*
|
1999-07-06 |
2003-06-10 |
Sinuspharma, Inc. |
Aerosolized anti-infectives, anti-inflammatories, and decongestants for the treatment of sinusitis
|
PT1955700E
(pt)
|
1999-09-30 |
2011-05-04 |
Harbor Biosciences Inc |
Tratamento terap?utico de doen?as associadas ao receptor de androg?nios
|
WO2001049268A1
(en)
*
|
2000-01-05 |
2001-07-12 |
Imarx Therapeutics, Inc. |
Pharmaceutical formulations for the delivery of drugs having low aqueous solubility
|
US20040009229A1
(en)
*
|
2000-01-05 |
2004-01-15 |
Unger Evan Charles |
Stabilized nanoparticle formulations of camptotheca derivatives
|
DE10116197A1
(de)
*
|
2001-03-30 |
2002-10-17 |
Bernina Biosystems Gmbh |
Neue Methylprednisolonderivate mit therapeutischer Wirkung
|
WO2003070745A2
(en)
*
|
2002-02-20 |
2003-08-28 |
Sepracor Inc. |
Carbonate and carbamate modified forms of glucocorticoids
|
US20050009798A1
(en)
|
2002-02-20 |
2005-01-13 |
Sepracor Inc. |
Carbonate and carbamate modified forms of glucocorticoids in combination with B2 adrenergic agonists
|
AU2003230600B2
(en)
*
|
2002-03-05 |
2009-06-04 |
Transave, Inc. |
An inhalation system for prevention and treatment of intracellular infections
|
US20040235811A1
(en)
*
|
2002-10-08 |
2004-11-25 |
Sepracor Inc. |
Fatty acid modified forms of glucocorticoids
|
US7718189B2
(en)
|
2002-10-29 |
2010-05-18 |
Transave, Inc. |
Sustained release of antiinfectives
|
CN1747738B
(zh)
*
|
2002-10-29 |
2010-11-24 |
川塞夫有限公司 |
缓释抗感染剂
|
US7879351B2
(en)
*
|
2002-10-29 |
2011-02-01 |
Transave, Inc. |
High delivery rates for lipid based drug formulations, and methods of treatment thereof
|
AU2003257154A1
(en)
*
|
2003-08-05 |
2005-03-07 |
Sepracor Inc. |
AMINO ACID AND PEPTIDE-MODIFIED FORMS OF GLUCOCORTICOIDS IN COMBINATION WITH ss2 ADRENERGIC AGONISTS
|
HUE029994T2
(en)
|
2005-12-08 |
2017-04-28 |
Insmed Inc |
Lipid-based preparations of antinfectants for the treatment of lung infections
|
NO331891B1
(no)
*
|
2007-03-20 |
2012-04-30 |
Clavis Pharma Asa |
Kjemiske forbindelser, et farmasoytisk preparat inneholdende slike forbindelser, samt anvendelse derav for behandling av kreft, inflammasjon og KOLS
|
US20100196455A1
(en)
|
2007-05-04 |
2010-08-05 |
Transave, Inc. |
Compositions of Multicationic Drugs for Reducing Interactions with Polyanionic Biomolecules and Methods of Use Thereof
|
US9114081B2
(en)
|
2007-05-07 |
2015-08-25 |
Insmed Incorporated |
Methods of treating pulmonary disorders with liposomal amikacin formulations
|
US9119783B2
(en)
|
2007-05-07 |
2015-09-01 |
Insmed Incorporated |
Method of treating pulmonary disorders with liposomal amikacin formulations
|
US9333214B2
(en)
|
2007-05-07 |
2016-05-10 |
Insmed Incorporated |
Method for treating pulmonary disorders with liposomal amikacin formulations
|
US20150272880A1
(en)
|
2012-05-21 |
2015-10-01 |
Insmed Incorporated |
Systems for treating pulmonary infections
|
BR112015012351A8
(pt)
|
2012-11-29 |
2019-10-01 |
Insmed Inc |
composição de antibiótico de glicopeptídeo à base de lipídeo estabilizado e uso de um componente lipídico, um componente de antibiótico de glicopeptídeo e um aminoácido ou derivado do mesmo
|
PL3142643T3
(pl)
|
2014-05-15 |
2019-12-31 |
Insmed Incorporated |
Sposoby leczenia zakażeń płuc prątkami niegruźliczymi
|
KR101961484B1
(ko)
*
|
2016-01-08 |
2019-03-22 |
최규선 |
생콩 탈피장치
|
JP7460534B2
(ja)
|
2018-03-30 |
2024-04-02 |
インスメッド インコーポレイテッド |
リポソーム医薬品の連続製造方法
|